HOME >> BIOLOGY >> NEWS
TIGR completes study providing insight into infectious strain of bacterium that causes otitis, pneumonia and meningitis

ROCKVILLE, MD Investigators at The Institute for Genomic Research (TIGR) today announced that they have determined the complete genome sequence of a virulent isolate (a very infectious strain) of Streptococcus pneumoniae or pneumococcus, the bacterium which causes over 3 million children and even more elderly people to die every year from pneumonia or meningitis. It is also the most common cause of otitis media or ear infection.

Herv Tettelin, Ph.D., principal investigator for the project, led the team at TIGR that determined the order of all of the 2.16 million individual chemical base units making up S. pneumoniaes DNA. This study, reported in the July 20 issue of Science, represents the 26th genome sequencing project completed by TIGR.

S. pneumoniae is one of the most significant bacterial pathogens of humans in terms of morbidity and mortality and this situation is compounded by a progressive increase in antibiotic resistance, particularly to penicillin and to other commonly used antibiotics, that has been observed worldwide. This increased resistance complicates the ability to treat pneumococcal infections and is focusing greater attention on prevention strategies. Undoubtedly, the availability of the complete genome sequence will provide additional avenues for follow-up studies on the basic biology and pathogenicity of this important pathogen.

Genome analysis revealed a number of novel insights relevant to the biology of S. pneumoniae including: the observation that 5% of the genome is composed of repeats (pieces of DNA that are found in several locations in the genome) that may facilitate incorporation of foreign DNA into the S. pneumoniae chromosome and contribute to rearranging its structure; the description of a new sequence motif that may be involved in bringing proteins to the surface of the bacteria, including virulence factors and a novel large protein composed of 540 repeat modules that could play a role in adhesion to huma
'"/>

Contact: Sharon Dukes
sdukes@tigr.org
301-610-5969
The Institute for Genomic Research
19-Jul-2001


Page: 1 2

Related biology news :

1. OneWorld Health completes enrollment, treatment in Phase III India trial
2. Third piece completes deadly puzzle: Structure of anthrax toxin offers clues to treatment
3. NTP completes 500th two-year rodent study and report; series is the gold standard of animal toxicology
4. DoubleTwist completes the first annotation of the human genome
5. Student science contest participation influences study, career choices, alumni say
6. New study shows hope for treating inhalant abuse
7. International study findings link acne-like rash to effectiveness of new targeted cancer treatment
8. Cigarette smoke causes breaks in DNA and defects to a cells chromosomes, Pitt study finds
9. New study indicates arsenic could be suitable as first-line treatment in type of leukaemia
10. Phase II trials of second-generation antisense cancer drug planned following successful early study
11. Preclinical safety study shows adipose-derived stem cells improve heart function after heart attack

Post Your Comments:
(Date:5/17/2013)... An international team of scientists using a new ... inside a living frog embryo in greater detail than ... advance biological research and the search for new treatments ... Karlsruher Institut fr Technologie in Germany, in collaboration with ... Energy,s Argonne National Laboratory, released the most precise depiction ...
(Date:5/16/2013)... FASEB MARC (Maximizing Access to Research Careers) Program ... Endocrine Society (ENDO) 95th Annual Meeting in San ... are meant to promote the entry of students, ... mainstream of the basic science community and to ... ENDO 2013 Annual Meeting. , Awards are given ...
(Date:5/16/2013)... living closer to a fast food restaurant had a ... further away from fast food, according to researchers at ... this association was particularly strong among those with a ... in the American Journal of Public Health ... fast food restaurant, and among lower-income African-Americans, the density, ...
Breaking Biology News(10 mins):New X-ray method shows how frog embryos could help thwart disease 2Body mass index of low income African-Americans linked to proximity of fast food restaurants 2Body mass index of low income African-Americans linked to proximity of fast food restaurants 3
(Date:5/17/2013)... Dr. Sparano is Professor of Medicine ... the Albert Einstein College of Medicine and Associate Chairman ... Center. He is also Associate Director for Clinical ... Einstein Breast Cancer Working Group, a multidisciplinary group of ... He also serves as Vice Chair of the National ...
(Date:5/17/2013)... The new Public-Private Partnership (PPP) in Photonics established ... annual meeting drew praise from community leaders from SPIE ... the action “a huge step forward … a lasting ... , The Board of Stakeholders voted to approve in ... its 29 April meeting in Brussels, which was sponsored ...
(Date:5/17/2013)... , May 17, 2013 /PRNewswire-iReach/ -- Aridis ... been reached with Switzerland -based ... anti-infective human monoclonal antibody (mAb) products, and technologies. ... mAb products for treatment of infections by common ... Staphylococcus aureus , Pseudomonas aeruginosa , ...
(Date:5/17/2013)... 17, 2013 Rust removal is one of ... home items could be damaged. To help rust contractors make ... its no-scrubbing rust remover it called Rusterizer. It ... with 10% discount. , My Cleaning Products explained that rust ... or by staining them. The first one, it said, ...
Breaking Biology Technology:Joseph A. Sparano, MD, Named Vice Chair of ECOG-ACRIN Cancer Research Group 2Joseph A. Sparano, MD, Named Vice Chair of ECOG-ACRIN Cancer Research Group 3SPIE Joins in Praise for ‘Huge Step Forward’ for Innovation R&D Enabled by Photonics21 Actions 2SPIE Joins in Praise for ‘Huge Step Forward’ for Innovation R&D Enabled by Photonics21 Actions 3Aridis Pharmaceuticals Announces Acquisition of Monoclonal Antibody Products and Technologies From Kenta Biotech 2Aridis Pharmaceuticals Announces Acquisition of Monoclonal Antibody Products and Technologies From Kenta Biotech 3Organic-Based Rust Remover Cuts Down Price by 10%, My Cleaning Products Details Mechanics How to Get the Discount 2
Cached News: